2022.a. publikatsioonid

Kokku publikatsioone: 200

Artiklid rahvusvahelistes ajakirjades
1Adoberg A., Paats J., Arund J., Dhondt A., Fridolin I., Glorieux G., Holmar J., Lauri K., Leis L., Luman M., Pilt K., Uhlin F., Tanner R.
Treatment with Paracetamol Can Interfere with the Intradialytic Optical Estimation in Spent Dialysate of Uric Acid but Not of Indoxyl Sulfate
PUBMED
Toxins: 14 (9), Artikkel nr 610, 2022
2Ala-Kokko T., Erikson K., Koskenkari J., Laurila J., Kortelainen J.
Monitoring of nighttime EEG slow-wave activity during dexmedetomidine infusion in patients with hyperactive ICU delirium: An observational pilot study
PUBMED
Acta Anaesthesiologica Scandinavica: 66 (10), 1211-1218, 2022
3Banach M., Reiner Z., Cicero AFG., Sabouret P., Viigimaa M., Sahebkar A., Postadzhiyan A., Gaita D., Pella D., Penson PE.
2022: the year in cardiovascular disease - the year of upfront lipid lowering combination therapy
PUBMED
Archives of Medical Science: 18 (6), 1429-1434, 2022
4Berger MM., Shenkin A., Schweinlin A., Amrein K., Augsburger M., Biesalski HK., Bischoff SC., Casaer MP., Gundogan K., Lepp HL., de Man AME., Muscogiuri G., Pietka M., Pironi L., Rezzi S., Cuerda C.
ESPEN micronutrient guideline
PUBMED
Clinical Nutrition: 41 (6), 1357-1424, 2022
5Blöndal M., Ainla T., Eha J., Lõiveke P., Marandi T., Saar A., Veldre G., Edfors R., Lewinter C., Jernberg T., Jortveit J., Halvorsen S., Becker D., Csanadi Z., Ferenci T., Andreka P., Janosi A.
Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway, and Sweden according to national ongoing registries
PUBMED
European Heart Journal. Quality of Care & Clinical Outcomes: 8 (3), 307-314, 2022
6Boria F., Chiva L.,Chacon E., Zanagnolo V., Fagotti A., Kucukmetin A., Mom C., Chakalova G., Shamistan A., Malzoni M., ..., Kukk K., SUCCOR study group
Autorite grupp:Leht M., Uppin A.
SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer
International Journal of Gynecological Cancer: 32 (10), 1236-1243, 2022
7Boriani G., Vitolo M., Malavasi VL., Proietti M., Fantecchi E., Diemberger I., Fauchier L., Marin F., Nabauer M., Potpara TS., ..., ESC-EHRA EORP-AF Long-Term General Registry Investigators
Autorite grupp:Muda P., Vettus R.
Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation (EORP-AF) general long-term registry
PUBMED
European Journal of Preventive Cardiology: 29 (15), 1967-1981, 2022
8Chacon E., Manzour N., Zanagnolo V., Querleu D., Nunez-Cordoba JM., Martin-Calvo N., Capilna ME., Fagotti A., Kucukmetin A., Mom C., ..., Kukk K., SUCCOR study group
Autorite grupp:Leht M., Uppin A.
SUCCOR cone study: conization before radical hysterectomy
PUBMED
International Journal of Gynecological Cancer: 32 (2), 117-124, 2022
9Cimci M., Polad J., Mamas M., Iniguez-Romo A., Chevalier B., Abhaichand R., Aminian A., Roguin A., Maluenda G., Angioi M., Cassel G., Kuramitsu S., Jacobs L., Debrus R., Malik F., Hildick-Smith D., Laanmets P., Roffi M., e-ULTIMASTER investigators
Outcomes and regional differences in practice in a worldwide coronary stent registry
PUBMED
Heart: 108 (16), 1310-1318, 2022
10Clark D., Joannides A., Adeleye AO., Bajamal AH., Bashford T., Biluts H., Budohoski K., Ercole A., Fernandez-Mendez R., Figaji A., ..., Global Neurotrauma Outcomes Study collaborative
Autorite grupp:Asser A., Kõiv K., Kõiv L., Rätsep T.
Casemix, management, and mortality of patients receiving emergency neurosurgery for traumatic brain injury in the Global Neurotrauma Outcomes Study: a prospective observational cohort study
PUBMED
The Lancet Neurology: 21 (5), 438-449, 2022
11Cook A., Sharland M., Yau Y., PediBSI Group, Bielicki J.
Autorite grupp:Kõljalg S., Jürna-Ellam M.
Improving empiric antibiotic prescribing in pediatric bloodstream infections: a potential application of weighted-incidence syndromic combination antibiograms (WISCA)
PUBMED
Expert Review of Anti-infective Therapy: 20 (3), 445-456, 2022
12Crulli B., Dines AM., Blanco G., Giraudon I., Eyer F., Liechti ME., Miro O., Hovda KE., Heyerdahl F., Yates C., Vallersnes OM., Wood DM., Dargan PI., Euro-DEN Plus Research Group
Autorite grupp:Põld K.
Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014-2019
PUBMED
Clinical Toxicology: 60 (12), 1318-1327, 2022
13Ding WY., Potpara TS., Blomström-Lundqvist C., Boriani G., Marin F., Fauchier L., Lip GYH., ESC-EHRA EORP-AF Long-Term General Registry Investigators
Autorite grupp:Muda P., Vettus R.
Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry
PUBMED
European Journal of Clinical Investigation: 52 (6), Artikkel nr e13745, 2022
14Ding WY., Proietti M., Boriani G., Fauchier L., Blomström-Lundqvist C., Marin F., Potpara TS., Lip GYH., ESC-EHRA EORP-AF Long-Term General Registry Investigators
Autorite grupp:Muda P., Vettus R.
Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry
PUBMED
Europace: 24 (5), 721-728, 2022
15Driemeyer C., Falci DR., Hoenigl M., Cornely OA., Chakrabarti A., Gangneux JP., Segal E., Jürna-Ellam M., Matos T., Meis JF., Perfect JR., Arsenijevic VA., Mares M., Serban DE., Pasqualotto AC.
The current state of Clinical Mycology in Eastern and South-Eastern Europe
PUBMED
Medical Mycology: 60 (4), Artikkel nr myac017, 2022
16Edfors R., Jernberg T., Lewinter C., Blöndal M., Eha J., Lõiveke P., Marandi T., Ainla T., Saar A., Veldre G., Ferenci T., Andreka P., Janosi A., Jortveit J., Halvorsen S.
Differences in characteristics, treatments and outcomes in patients with non-ST-elevation myocardial infarction - novel insights from four national European continuous real-world registries
PUBMED
European Heart Journal. Quality of Care & Clinical Outcomes: 8 (4), 429-436, 2022
17Eger K., Paroczai D., Bacon A., Schleich F., Sergejeva S., Bourdin A., Vachier I., Zervas E., Katsoulis K., Papapetrou D., ...
The effect of the COVID-19 pandemic on severe asthma care in Europe: will care change for good?
PUBMED
ERJ Open Research: 8 (2), Artikkel nr 00065-2022, 2022
18Einstein AJ., Hirschfeld C., Williams MC., Vitola JV., Better N., Villines TC., Cerci R., Shaw LJ., Choi AD., Dorbala S., ..., INCAPS COVID 2 Investigators Group
Autorite grupp:Liiver A.
Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19
PUBMED
Journal of the American College of Cardiology: 79 (20), 2001-2017, 2022
19Eroglu Z., Broman KK., Thompson JF., Nijhuis A., Hieken TJ., Kottschade L., Farma JM., Hotz M., Deneve J., Fleming M., ..., Teras J.
Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection
PUBMED
Journal for ImmunoTherapy of Cancer: 10 (8), Artikkel nr e004417, 2022
20Frix AN., Heaney LG., Dahlen B., Mihaltan F., Sergejeva S., Popovic-Grle S., Sedlak V., Lehtimäki L., Bourdin A., Korn S., ...
Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study
PUBMED
ERJ Open Research: 8 (4), Artikkel nr 00273-2022, 2022
21Fuchs CS., Özgüroglu M., Bang YJ., Di Bartolomeo M., Mandala M., Ryu MH., Fornaro L., Olesinski T., Caglevic C., Chung HC., ..., Elme A.
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial
PUBMED
Gastric Cancer: 25 (1), 197-206, 2022
22Glikson M., Nielsen JC., Kronborg MB., Michowitz Y., Auricchio A., Barbash IM., Barrabes JA., Boriani G., Braunschweig F., Brignole M., ...
Autorite grupp:Voitk J.
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
PUBMED
Europace: 24 (1), 71-164, 2022
23GlobalSurg Collaborative and NIHR Global Health Research Unit on Global Surgery
Autorite grupp:Kütner S., Melnik P., Seire I., Teras J., Ümarik T., Teppo S.
Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study
PUBMED
The Lancet Global Health: 10 (7), e1003-e1011, 2022
24Goncalves BP., Hall M., Jassat W., Balan V., Murthy S., Kartsonaki C., Semple MG., Rojek A., Baruch J., Reyes LF., ..., ISARIC Clinical Characterisation Group
Autorite grupp:Rätsep I.
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients
PUBMED
eLife: 11, Artikkel nr e80556, 2022
25Grüßer L., Keszei A., Coburn M., Rossaint R., Ziemann S., Kowark A., ETPOS Study Group
Autorite grupp:Karjagin J., Rokk A., Sõrmus A., Rätsep I., Oganjan J., Smirnova N., Kivik P.
Intraoperative transfusion practices and perioperative outcome in the European elderly: A secondary analysis of the observational ETPOS study
PUBMED
PLoS ONE: 17 (1), Artikkel nr e0262110, 2022
26Hagström E., Steg PG., Szarek M., Bhatt DL., Bittner VA., Danchin N., Diaz R., Goodman SG., Harrington RA., Jukema JW., ..., ODYSSEY OUTCOMES Investigators
Autorite grupp:Viigimaa M.
Apolipoprotein B., Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
PUBMED
Circulation: 146 (9), 657-672, 2022
27Heier EC., Eyer F., Rabe C., Geith S., Dargan PI., Wood DM., Heyerdahl F., Dines AM., Giraudon I., Hovda KE., Yates C., Vallersnes OM., Miro O., Liechti ME., Zellner T., Euro-DEN Research Group
Autorite grupp:Põld K.
Clinical effect of ethanol co-use in patients with acute drug toxicity involving the use of central nervous system depressant recreational drugs
PUBMED
European Journal of Emergency Medicine: 29 (4), 291-300, 2022
28Hellgren T., Blöndal M., Jortveit J., Ferenci T., Faxen J., Lewinter C., Eha J., Lõiveke P., Marandi T., Ainla T., Saar A., Veldre G., Andreka P., Halvorsen S., Janosi A., Edfors R.
Sex-related differences in the management and outcomes of patients hospitalized with ST-elevation myocardial infarction: a comparison within four European myocardial infarction registries
PUBMED
European Heart Journal Open: 2 (4), Artikkel nr oeac042, 2022
29Hendricks LAJ., Hoogerbrugge N., Venselaar H., Aretz S., Spier I., Legius E., Brems H., de Putter R., Claes KBM., Evans DG., ..., Roht L.
Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort
PUBMED
European Journal of Medical Genetics: 65 (12), Artikkel nr 104632, 2022
30Holmberg CJ., Ny L., Hieken TJ., Block MS., Carr MJ., Sondak VK., Örtenwall C., Katsarelias D., Dimitriou F., Menzies AM., ..., Teras J.
The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases - A multicenter cohort study
PUBMED
European Journal of Cancer: 169, 210-222, 2022
31Humbert M., Kovacs G., Hoeper MM., Badagliacca R., Berger RMF., Brida M., Carlsen J., Coats AJS., Escribano-Subias P., Ferrari P., ...
Autorite grupp:Anton L.
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
PUBMED
European Heart Journal: 43 (38), 3618-3731, 2022
32Innos K., Paapsi K., Alas I., Baum P., Kivi M., Kovtun M., Okas R., Pokker H., Rajevskaja O., Rautio A., Saretok M., Valk E., Žarkovski M., Denissov G., Lang K.
Evidence of overestimating prostate cancer mortality in Estonia: a population-based study
PUBMED
Scandinavian Journal of Urology: 56 (5-6), 359-364, 2022
33ISARIC Clinical Characterization Group, Garcia-Gallo E., Merson L., Kennon K., Kelly S., Citarella BW., Fryer DV., Shrapnel S., Lee J., Duque S., ...
Autorite grupp:Beljantsev A., Maasikas O., Mihnovitš V., Rätsep I.
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
PUBMED
Scientific Data: 9 (1), Artikkel nr 454, 2022
34Jaago M., Rähni A., Pupina N., Pihlak A., Sadam H., Tuvikene J., Avarlaid A., Planken A., Planken M., Haring L., Vasar E., Bacevic M., Lambert F., Kalso E., Pussinen P., Tienari PJ., Vaheri A., Lindholm D., Timmusk T., Ghaemmaghami AM., Palm K.
Differential patterns of cross-reactive antibody response against SARS-CoV-2 spike protein detected for chronically ill and healthy COVID-19 naive individuals
PUBMED
Scientific Reports: 12 (1), Artikkel nr 16817, 2022
35Jaakonmäki N., Zedde M., Sarkanen T., Martinez-Majander N., Tuohinen S., Sinisalo J., Ryödi E., Autere J., Hedman M., Junttola U., ..., Kõrv L., Kõrv J.
Obesity and the Risk of Cryptogenic Ischemic Stroke in Young Adults
PUBMED
Journal of Stroke and Cerebrovascular Diseases: 31 (5), Artikkel nr 106380, 2022
36Jalasto J., Lassmann-Klee P., Schyllert C., Luukkonen R., Meren M., Larsson M., Põlluste J., Sundblad BM., Lindqvist A., Krokstad S., Kankaanranta H., Kauppi P., Sovijärvi A., Haahtela T., Backman H., Lundbäck B., Piirilä P.
Occupation, socioeconomic status and chronic obstructive respiratory diseases - The EpiLung study in Finland, Estonia and Sweden
PUBMED
Respiratory Medicine: 191, Artikkel nr 106403, 2022
37Janssen BDE., van den Boogaard MH., Lichtenbelt K., Seaby EG., Stals K., Ellard S., Newbury-Ecob R., Dixit A., Roht L., Pajusalu S., Õunap K., ...
De novo putative loss-of-function variants in TAF4 are associated with a neuro-developmental disorder
PUBMED
Human Mutation: 43 (12), 1844-1851, 2022
38Jürgens H., Roht L., Leitsalu L., Nõukas M., Palover M., Nikopensius T., Reigo A., Kals M., Kallak K., Kütner R., Budrikas K., Kuusk S., Valvere V., Laidre P., Toome K., Rekker K., Tooming M., Murumets Ü., Kahre T., Kruuv-Käo K., Õunap K., Padrik P., Metspalu A., Esko T., Fischer K., Tõnisson N.
Precise, Genotype-First Breast Cancer Prevention: Experience With Transferring Monogenic Findings From a Population Biobank to the Clinical Setting
PUBMED
Frontiers in Genetics: 13, Artikkel nr 881100, 2022
39Kangro K., Kurašin M., Gildemann K., Sankovski E., Žusinaite E., Lello LS., Pert R., Kavak A., Poikalainen V., Lepasalu L., Kuusk M., Pau R., Piiskop S., Rom S., Oltjer R., Tiirik K., Kogermann K., Plaas M., Tiirats T., Aasmäe B., Plaas M., Mumm K., Krinka D., Talpsep E., Kadaja M., Gerhold JM., Planken A., Tover A., Merits A., Männik A., Ustav M. Jr., Ustav M.
Bovine colostrum-derived antibodies against SARS-CoV-2 show great potential to serve as prophylactic agents
PUBMED
PLoS ONE: 17 (6), Artikkel nr e0268806, 2022
40Kobo O., Saada M., Laanmets P., Karageorgiev D., Routledge H., Crowley J., Baello P., Requena JB., Spano F., Perez L., Jimenez Mazuecos JM., Mamas MA., Roguin A.
Impact of peripheral artery disease on prognosis after percutaneous coronary intervention: Outcomes from the multicenter prospective e-ULTIMASTER registry
PUBMED
Atherosclerosis: 344, 71-77, 2022
41Krieger B., Hallik R., Kala K., Ülper K., Polonski M.
Validation of mobile-based funduscope for diabetic retinopathy screening in Estonia
PUBMED
European Journal of Ophthalmology: 32 (1), 508-513, 2022
42Kroese TE., van Hillegersberg R., Schoppmann S., Deseyne PRAJ., Nafteux P., Obermannova R., Nordsmark M., Pfeiffer P., Hawkins MA., Smyth E., ..., Elme A.
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe
PUBMED
European Journal of Cancer: 164, 18-29, 2022
43Kulasekararaj AG., Griffin M., Langemeijer S., Usuki K., Kulagin A., Ogawa M., Yu J., Mujeebuddin A., Nishimura JI., Lee JW., Peffault de Latour R., 301/302 Study Group
Autorite grupp:Viigimaa I.
Long-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2-year results from two pivotal phase 3 studies
PUBMED
European Journal of Haematology: 109 (3), 205-214, 2022
44Kurg K., Planken A., Kurg R.
Proteomic and Biochemical Analysis of Extracellular Vesicles Isolated from Blood Serum of Patients with Melanoma
Separations: 9 (4), Artikkel nr 86, 2022
45Li Bassi G., Gibbons K., Suen JY., Dalton HJ., White N., Corley A., Shrapnel S., Hinton S., Forsyth S., Laffey JG., ..., COVID-19 Critical Care Consortium
Autorite grupp:Rätsep I., Õigus G., Erikson K., Enneveer L., Maasikas O., Beljantsev A., Mihnovitš V.
Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis
PUBMED
Critical Care: 26 (1), Artikkel nr 141, 2022
46Lip GYH., Kotalczyk A., Teutsch C., Diener HC., Dubner SJ., Halperin JL., Ma CS., Rothman KJ., Marler S., Gurusamy VK., Huisman MV., GLORIA-AF Investigators
Autorite grupp:Kampus P.
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry
PUBMED
Clinical Research in Cardiology: 111 (5), 560-573, 2022
47Loberti L., Bruno LP., Granata S., Doddato G., Resciniti S., Fava F., Carullo M., Rahikkala E., Jouret G., Menke LA., ..., Reimand T., Lokke H., Õunap K., Zordania R., Muru K., Roht L., Teek R., Thomson U.
Natural history of KBG syndrome in a large European cohort
PUBMED
Human Molecular Genetics: 31 (24), 4131-4142, 2022
48Lõokene M., Markov N., Nikander M., Neuvonen T., Dilkov D.
Reduction of symptoms in patients with major depressive disorder after transcranial direct current stimulation treatment: A real-world study
Journal of Affective Disorders Reports: 8, Artikkel nr 100347, 2022
49Lyon AR., Lopez-Fernandez T., Couch LS., Asteggiano R., Aznar MC., Bergler-Klein J., Boriani G., Cardinale D., Cordoba R., Cosyns B., ..., ESC Scientific Document Group
Autorite grupp:Vettus R.
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
PUBMED
European Heart Journal: 43 (41), 4229-4361, 2022
50Malavasi VL., Vitolo M., Proietti M., Diemberger I., Fauchier L., Marin F., Nabauer M., Potpara TS., Dan GA., Kalarus Z., ..., ESC-EHRA EORP-AF Long-Term General Registry Investigators
Autorite grupp:Muda P., Vettus R.
Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry
PUBMED
European Journal of Clinical Investigation: 52 (7), Artikkel nr e13773, 2022
51Manzour N., Chiva L., Chacon E., Martin-Calvo N., Boria F., Minguez JA., Alcazar JL., SUCCOR Study Group
Autorite grupp:Kukk K., Leht M., Uppin A.
SUCCOR Risk: Design and Validation of a Recurrence Prediction Index for Early-Stage Cervical Cancer
PUBMED
Annals of Surgical Oncology: 29 (8), 4819-4829, 2022
52Martin-Loeches I., Timsit JF., Kollef MH., Wunderink RG., Shime N., Novacek M., Kivistik Ü., Rea-Neto A., Bruno CJ., Huntington JA., Lin G., Jensen EH., Motyl M., Yu B., Gates D., Butterton JR., Rhee EG.
Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia
PUBMED
Journal of Antimicrobial Chemotherapy: 77 (4), 1166-1177, 2022
53Medved S., Žaja N., Gazdag G., Lengvenyte A., Mörkl S., Mucci F., Ristic I., Jerotic S., Regente JF., Ivanovic I., ..., Lõokene M.
Preliminary Assessment of Pre-Electroconvulsive Therapy Evaluation Practices in European Countries: The Need for Guidelines
PUBMED
Journal of ECT: 38 (4), 230-237, 2022
54Murruste M., Kirsimägi Ü., Kase K., Veršinina T., Talving P., Lepner U.
Complications of chronic pancreatitis prior to and following surgical treatment: A proposal for classification
PUBMED
World Journal of Clinical Cases: 10 (22), 7808-7824, 2022
55Naaber P., Tserel L., Kangro K., Punapart M., Sepp E., Jürjenson V., Kärner J., Haljasmägi L., Haljasorg U., Kuusk M., Sankovski E., Planken A., Ustav M., Žusinaite E., Gerhold JM., Kisand K., Peterson P.
Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine
PUBMED
Cell Reports Medicine: 3 (8), Artikkel nr 100716, 2022
56Nurm M., Reigo A., Nõukas M., Leitsalu L., Nikopensius T., Palover M., Annilo T., Alver M., Saar A., Marandi T., Ainla T., Metspalu A., Esko T., Tõnisson N.
Do Biobank Recall Studies Matter? Long-Term Follow-Up of Research Participants With Familial Hypercholesterolemia
PUBMED
Frontiers in Genetics: 13, Artikkel nr 936131, 2022
57O'Brien M., Paz-Ares L., Marreaud S., Dafni U., Oselin K., Havel L., Esteban E., Isla D., Martinez-Marti A., Faehling M., ...
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
PUBMED
The Lancet Oncology: 23 (10), 1274-1286, 2022
58Paz-Ares L., O'Brien MER., Mauer M., Dafni U., Oselin K., Havel L., Gonzalez EE., Isla D., Martinez-Marti A., Faehling M., ...
VP3-2022: Pembrolizumab (pembro) versus placebo for early-stage non-small cell lung cancer (NSCLC) following complete resection and adjuvant chemotherapy (chemo) when indicated: Randomized, triple-blind, phase III EORTC-1416-LCG/ETOP 8-15 e PEARLS/KEYNOTE-091 study
Annals of Oncology: 33 (4), 451-453, 2022
59Pauklin P., Zilmer M., Eha J., Tootsi K., Kals M., Kampus P.
Markers of Inflammation, Oxidative Stress, and Fibrosis in Patients with Atrial Fibrillation
PUBMED
Oxidative Medicine and Cellular Longevity: Artikkel nr 4556671, 2022
60Peebo K., Saluveer E., Küünarpuu H., Orgse T., Harro J.
First-episode psychosis integrative treatment: Estonian experience
PUBMED
Nordic Journal of Psychiatry: 76 (3), 207-214, 2022
61PelvEx Collaborative
Autorite grupp:Teras J.
Contemporary Management of Locally Advanced and Recurrent Rectal Cancer: Views from the PelvEx Collaborative
PUBMED
Cancers: 14 (5), Artikkel nr 1161, 2022
62PelvEx Collaborative
Autorite grupp:Teras J.
Minimum standards of pelvic exenterative practice: PelvEx Collaborative guideline
PUBMED
British Journal of Surgery: 109 (12), 1251-1263, 2022
63Penson PE., Bruckert E., Marais D., Reiner Ž., Pirro M., Sahebkar A., Bajraktari G., Mirrakhimov E., Rizzo M., Mikhailidis DP., ..., International Lipid Expert Panel (ILEP)
Autorite grupp:Viigimaa M.
Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)
PUBMED
Journal of Cachexia, Sarcopenia and Muscle: 13 (3), 1596-1622, 2022
64Pikta M., Vasse M., Smock KJ., Moser KA., Van Dievoet MA., Lejniece S., Szanto T., Bautista H., Nouadje G., Banys V.
Establishing reference intervals for von Willebrand factor multimers
PUBMED
Journal of Medical Biochemistry: 41 (1), 115-121, 2022
65Proietti M., Romiti GF., Vitolo M., Harrison SL., Lane DA., Fauchier L., Marin F., Näbauer M., Potpara TS., Dan GA., Maggioni AP., Cesari M., Boriani G., Lip GYH., ESC-EHRA EORP-AF General Long-Term Registry Investigators
Autorite grupp:Vettus R., Muda P.
Epidemiology and impact of frailty in patients with atrial fibrillation in Europe
PUBMED
Age and Ageing: 51 (8), Artikkel nr afac192, 2022
66Pupina N., Avarlaid A., Sadam H., Pihlak A., Jaago M., Tuvikene J., Rähni A., Planken A., Planken M., Kalso E., Tienari PJ., Nieminen JK., Seppänen MRJ., Vaheri A., Lindholm D., Sinisalo J., Pussinen P., Timmusk T., Palm K.
Immune response to a conserved enteroviral epitope of the major capsid VP1 protein is associated with lower risk of cardiovascular disease
PUBMED
EBioMedicine: 76, Artikkel nr 103835, 2022
67Ratanachina J., Amaral AFS., De Matteis S., Lawin H., Mortimer K., Obaseki DO., Harrabi I., Denguezli M., Wouters EFM., Janson C., ..., Jõgi R., BOLD Collaborative Research Group
Autorite grupp:Laja H., Ulst K., Zobel V.
Association of respiratory symptoms and lung function with occupation in the multinational Burden of Obstructive Lung Disease (BOLD) study
PUBMED
European Respiratory Journal: 60 (4), Artikkel nr 2200469, 2022
68Raukas M., Metsna V., Tammaru M.
Cross-cultural adaptation and validation of the Estonian version of the Oxford Knee Score
PUBMED
Acta Orthopaedica et Traumatologica Turcica: 56 (1), 53-57, 2022
69Reuter A., Rogge L., Monahan M., Kachapila M., Morton DG., Davies J., Vollmer S., NIHR Global Surgery Collaboration
Autorite grupp:Talving P., Saar S., Reinsoo A.
Global economic burden of unmet surgical need for appendicitis
PUBMED
British Journal of Surgery: 109 (10), 995-1003, 2022
70Reyes LF., Murthy S., Garcia-Gallo E., Merson L., Ibanez-Prada ED., Rello J., Fuentes YV., Martin-Loeches I., Bozza F., Duque S., ..., ISARIC Characterization Group
Autorite grupp:Beljantsev A., Maasikas O., Mihnovitš V., Rätsep I.
Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study
PUBMED
Critical Care: 26 (1), Artikkel nr 276, 2022
71Rips L., Luik M., Koovit T., Rahu M.
Lower leg muscle recovery takes at least 12 months for functional tests to recover after late reconstruction of the tibialis posterior tendon retinaculum
PUBMED
BMJ Case Reports: 15 (1), Artikkel nr e247273, 2022
72Rips L., Toom A., Kuik R., Varblane A., Mölder H., Tammaru M., Kull M., Ööpik V., Kartus JT., Gapeyeva H., Rahu M.
Seven-month wintertime supplementation of 1200 IU vitamin D has no effect on hand grip strength in young, physically active males: A randomized, controlled study
PUBMED
Journal of the International Society of Sports Nutrition: 19 (1), 437-454, 2022
73Roht L., Tooming M., Rekker K., Roomere H., Toome K., Murumets Ü., Šamarina U., Õunap K., Kahre T.
The prevalence of germline pathogenic variants in Estonian colorectal cancer patients: results from routine clinical setting 2016-2021
PUBMED
Frontiers in Genetics: 13, Artikkel nr 1020543, 2022
74Romiti GF., Proietti M., Vitolo M., Bonini N., Fawzy AM., Ding WY., Fauchier L., Marin F., Nabauer M., Dan GA., ..., ESC-EHRA EORP-AF General Long-Term Registry Investigators
Autorite grupp:Muda P., Vettus R.
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry
PUBMED
BMC Medicine: 20 (1), Artikkel nr 326, 2022
75Rubin DT., Dotan I., DuVall A., Bouhnik Y., Radford-Smith G., Higgins PDR., Mishkin DS., Arrisi P., Scalori A., Oh YS., Tole S., Chai A., Chamberlain-James K., Lacey S., McBride J., Panes J., HIBISCUS Study Group
Autorite grupp:Kull K., Borissova J.
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials
PUBMED
The Lancet Gastroenterology and Hepatology: 7 (1), 17-27, 2022
76Saar S., Jorgensen J., Lemma AN., Gaarder C., Naess PA., Leppäniemi A., Sallinen V., Pius R., Reinsoo A., Lepp J., Talving P.
Selective non-operative management of penetrating abdominal injuries at Northern European trauma centers: the NordiPen Study
PUBMED
European Journal of Trauma and Emergency Surgery: 48 (3), 2023-2027, 2022
77Schjesvold FH., Dimopoulos MA., Delimpasi S., Robak P., Coriu D., Legiec W., Pour L., Špicka I., Masszi T., Doronin V., ..., OCEAN (OP-103) Investigators
Autorite grupp:Palk K., Kaare A.
Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study
PUBMED
The Lancet Haematology: 9 (2), e98-e110, 2022
78Szanto T., Zetterberg E., Ramström S., Leinoe EB., Holme PA., Antovic JP., Holmström M., Onundarson PT., Pikta M., Vaide I., Olsson A., Magnusson M., Kärkkäinen S., Bitar M., Poulsen LH., Lassila R., Nordic Haemophilia Council
Platelet function testing: Current practice among clinical centres in Northern Europe
PUBMED
Haemophilia: 28 (4), 642-648, 2022
79Tamm M., Kals M., Annilo T., Oselin K., Keerma K., Kivistik PA., Nurm M., Saare M., Jaal J., Tõnisson N.
Prognostic Utility of Targeted Circulating Cell-Free DNA versus Formalin-Fixed Paraffin-Embedded DNA Mutation Analysis for Advanced Lung Cancer
International Journal of Oncology Research: 5 (1), Artikkel nr 033, 2022
80Timmis A., Vardas P., Townsend N., Torbica A., Katus H., De Smedt D., Gale CP., Maggioni AP., Petersen SE., Huculeci R., Kazakiewicz D., ..., Atlas Writing Group, European Society of Cardiology
Autorite grupp:Kampus P.
European Society of Cardiology: cardiovascular disease statistics 2021
PUBMED
European Heart Journal: 43 (8), 716-799, 2022
81Urner M., Barnett AG., Bassi GL., Brodie D., Dalton HJ., Ferguson ND., Heinsar S., Hodgson CL., Peek G., Shekar K., Suen JY., Fraser JF., Fan E., COVID-19 Critical Care Consortium Investigators
Autorite grupp:Beljantsev A., Maasikas O., Mihnovitš V., Rätsep I., Õigus G., Enneveer L., Erikson K.
Venovenous extracorporeal membrane oxygenation in patients with acute covid-19 associated respiratory failure: comparative effectiveness study
PUBMED
BMJ: 377, Artikkel nr e068723, 2022
82Uusküla A., Keis A., Toompere K., Planken A., Rebrov K.
Cluster randomised, controlled, triple-blind trial assessing the efficacy of intranasally administered virus-neutralising bovine colostrum supplement in preventing SARS-CoV-2 infection in household contacts of SARS-CoV-2-positive individuals: a study protocol
PUBMED
Trials: 23 (1), Artikkel nr 92, 2022
83van Veelen A., Elias J., van Dongen IM., Hoebers LPC., Claessen BEPM., Ramunddal T., Laanmets P., Eriksen E., van der Schaaf RJ., Nijveldt R., Henriques JPS., Hirsch A.
Recovery of right ventricular function and strain in patients with ST-segment elevation myocardial infarction and concurrent chronic total occlusion
PUBMED
International Journal of Cardiovascular Imaging: 38 (3), 631-641, 2022
84Viigimaa M., Jürisson M., Pisarev H., Kalda R., Alavere H., Irs A., Saar A., Fischer K., Läll K., Kruuv-Käo K., Mars N., Widen E., Ripatti S., Metspalu A.
Effectiveness and feasibility of cardiovascular disease personalized prevention on high polygenic risk score subjects: a randomized controlled pilot study
PUBMED
European Heart Journal Open: 2 (6), Artikkel nr oeac079, 2022
85Örd L., Marandi T., Märk M., Raidjuk L., Kostjuk J., Banys V., Krause K., Pikta M.
Evaluation of DOAC Dipstick Test for Detecting Direct Oral Anticoagulants in Urine Compared with a Clinically Relevant Plasma Threshold Concentration
PUBMED
Clinical and Applied Thrombosis/Hemostasis: 28, Artikkel nr 10760296221084307, 2022
Artiklid "Eesti Arstis"
1Adoberg A., Auerbach A., Telling K., Mihnovitš V., Pertsev I., Kivistik Ü., Seppet J., Riispere Ž., Kõlvald K.
Orellaniinimürgistusest põhjustatud neerukahjustus – haigusjuhtude kirjeldus ja kirjanduse ülevaade
Eesti Arst: 101 (1), 43-48, 2022
2Ainla T.
Ideest teostuseni − müokardiinfarktiregistri teekond riikliku registrini 2000−2011
Eesti Arst: 101 (Lisa 1), 3-6, 2022
3Jakobson L., Veede V.
Ravirefraktaarne alkoholvõõrutus: haigusjuhu kirjeldus ja kirjanduse ülevaade
Eesti Arst: 101 (10), 578-583, 2022
4Jürgenson A., Sooba E.
Põlve- ja puusaliigese endoproteesimise tõenduspõhise taastusravi korraldus
Eesti Arst: 101 (Lisa 3), 50-54, 2022
5Kiisla Ü., Sinimäe P.
Hormonaalse emakasisese rasestumisvastase süsteemi perforatsioon sigmasoolde. Haigusjuhu kirjeldus
Eesti Arst: 101 (12), 700-704, 2022
6Lepik T., Rätsep I.
Lemierre’i sündroom
Eesti Arst: 101 (5), 315-319, 2022
7Lillo KE.
Amatoksiinimürgistus. Kirjanduse ülevaade ja valge kärbseseene mürgistusega kahe patsiendi haigusjuht
Eesti Arst: 101 (6-7), 374-381, 2022
8Lõiveke P., Saar A.
Kuidas aitab müokardiinfarktiregister leida suurimat tähelepanu vajavaid, suurima suremusriskiga südamelihase infarktiga patsiente?
Eesti Arst: 101 (Lisa 1), 37-42, 2022
9Marandi T., Ainla T.
Müokardiinfarktiregistri tulevikuvisioon
Eesti Arst: 101 (Lisa 1), 50-51, 2022
10Marandi T., Ainla T., Blöndal M., Jürgenson A., Kivistik E., Lukmann A., Lõiveke P., Martinson K., Reinmets J., Saar A., Serg M.
Müokardiinfarktihaige käsitlus esimesel aastal pärast haigestumist
Eesti Arst: 101 (5), 324-328, 2022
11Nurm M.
Taastusravi arendamine Põhja-Eesti Taastusravikeskuses aastatel 1994-2020
Eesti Arst: 101 (Lisa 3), 13-18, 2022
12Orav K.
Epilepsia kirurgiline ravi – alakasutatud võimalus ravimrefraktaarse epilepsia raviks
Eesti Arst: 101 (8), 430-436, 2022
13Ott M., Haavistu L.
Püsiv somatoformne valu
Eesti Arst: 101 (1), 37-42, 2022
14Paal P., Krikmann K., Sikk K., Taba P., Elmet K., Suija K.
Palliatiivne ravi kui esmatasandi tervishoiuteenus – definitsioon, normid ja tavad
Eesti Arst: 101 (6-7), 349-355, 2022
15Piiskoppel P., Palm K.
Hüpertroofiline kardiomüopaatia
Eesti Arst: 101 (9), 495-500, 2022
16Raud M.
Brodie abstsess ja fibroosne kortikaalne defekt
Eesti Arst: 101 (10), 584-585, 2022
17Roosipuu A., Vettus E., Vettus R.
Nivolumabist tingitud hulgielundipuudulikkus haigusjuhu näitel
Eesti Arst: 101 (3), 183-187, 2022
18Ross M., Elme A.
Kommentaarid artikli „Trombotsütoos suurendab oluliselt pahaloomulise kasvaja riski” kohta
Eesti Arst: 101 (8), 448-449, 2022
19Saar S., Lipping E., Lepp J., Lepner U., Talving P.
Läbivate kõhuvigastuste selektiivne mitteoperatiivne käsitlus ning praktika Põhja-Euroopa traumakeskustes
Eesti Arst: 101 (4), 225-227, 2022
20Toming A., Kaljurand K.
Paratsentraalne akuutne keskmiste kihtide makulopaatia ehk silmapõhja isheemia võrkkesta sügavama kapillaaristiku tasemel – haigusjuhu kirjeldus
Eesti Arst: 101 (11), 636-640, 2022
21Tuulik VR., Jürgenson A., Vaht M.
Luu-lihaskonna kerge ja mõõduka astme ülekoormussündroomide mõjutamine soojus-, vesi- ja mudaraviga: toimemehhanismis ja efektiivsus
Eesti Arst: 101 (Lisa 3), 55-61, 2022
22Umov N., Kampus P.
Implanteeritavate südameaparaatide kaug-kodujälgimine
Eesti Arst: 101 (9), 487-493, 2022
23Vellend O., Gavrilkina J.
Munasarjastruuma. Haigusjuhu kirjeldus koos erialakirjanduse ülevaatega
Eesti Arst: 101 (4), 243-246, 2022
Raamatud, dissertatsioonid
1Erikson K.
The brain as an end organ in sepsis?
Acta Universitatis Ouluensis. D, Medica: 1663, 78, 2022
2Juus E., Laidroo O., Plaas M., Kiivet RA., Jürisson M.
Bioloogilised ravimid ninapolüpoosi ravis: tervisetehnoloogia hindamise raport TTH53
Bioloogilised ravimid ninapolüpoosi ravis: tervisetehnoloogia hindamise raport TTH53: 53, 2022
3Lutsar K., Alloja J., Oselin K., Rooväli L., Nurk K., Kiivet RA., Jürisson M.
Kaugelearenenud heledarakulise neeruvähi immuunravi kulutõhusus: tervisetehnoloogia hindamise raport TTH55
Kaugelearenenud heledarakulise neeruvähi immuunravi kulutõhusus: tervisetehnoloogia hindamise raport TTH55: 61, 2022
4Põld M., Lepp HL., Uibo O., Juus E., Oad S., Reinson K., Lember M., Saarsalu S., Kiivet RA., Jürisson M.
Suukaudse toitmisravi efektiivsus, kulud ja korraldus: tervisetehnoloogia hindamise raport TTH54
Suukaudse toitmisravi efektiivsus, kulud ja korraldus: tervisetehnoloogia hindamise raport TTH54: 72, 2022
Konverentsiteesid
1Adamson-Raieste A.
Cancer immunotherapy in early clinical development
Eesti Arst: 101 (Lisa 2), 27, 2022
2Bossios A., Bacon AM., Eger K., Paroczai D., Schleich F., Hanon S., Sergejeva S., Zervas E., Katsoulis K., Aggelopoulou A., ...
Beliefs about vaccination and relation to COVID-19 vaccination side-effects in asthma patients
European Respiratory Journal: 60 (Suppl 66), Tees nr 1085, 2022
3del Castillo FJ., Munoz G., Dominguez-Ruiz M., Ciubotariu C., Piris-Villaespesa M., Ley M., Gainza E., Unceta M., Ceberio L., Fdil N., Ross M., Belanger A., Villarrubia J.
NGS-based panel screening of suspected lysosomal disease cases identifies novel pathogenic variants underlying acid sphingomyelinase deficiency (ASMD), Krabbe disease, and lymphatic dysplasia with non-immune hydrops fetalis
Molecular Genetics and Metabolism: 135 (2), S36, 2022
4Eger K., Paroczai D., Bacon A., Schleich F., Sergejeva S., ...
The effect of the COVID-19 pandemic on severe asthma care in Europe - will care change for good?
European Respiratory Journal: 60 (Suppl 66), Tees nr 192, 2022
5Federico M., Stepanishyna Y., Skrypets T., Chiattone C., Prince MH., Pavlovsky A., Lymboussakis A., Manni M., Civallero M., de Souza CA., Hawkes EA., Fiad L., Nair R., Kriachok I., Hitz F., Kostina O., Tomuleasa C., Guarini A., Luminari S.
Mature T and NK cell lymphomas classified according to 2016 WHO classification. A report of the international prospective T-cell Project 2.0
Hemasphere: 6 (Suppl 3), 123-124, 2022
6Frix A., Heaney LG., Dahlen B., Mihaltan F., Sergejeva S., Doberer D., Popovic-Grle S., Sedlak V., Lehtimäki L., Bourdin A., ...
Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study
European Respiratory Journal: 60 (Suppl 66), Tees nr 2387, 2022
7Heinsar S., Bartnikowski N., Hartel G., Seah EP., Colombo SM., Farah SM., Rätsep I., Pauls J., Fraser JF., Suen J.
In vitro evaluation of hemodynamic energy production and circuit loss using four different ECMO arterial cannulae
Artificial Organs: 46 (1), E12-E13, 2022
8Iskül S., Zemtsovskaja G.
Pitfalls of introducing the methotrexate method in a highly automated laboratory
Clinica Chimica Acta: 530 (Suppl 1), S440, 2022
9Iskül S., Võsa L., Zemtsovskaja G.
Validating the Roche Cobas serum haemolysis index for the assessment of plasma cell-free haemoglobin concentration
Eesti Arst: 101 (Supplement 4), 39, 2022
10Keba M., Asser A.
Ülevaade elektrilise tõukerattaga sõitmise tagajärjel esinevatest ajutraumadest: haigusjuhtude analüüs Põhja-Eesti Regionaalhaiglas aastatel 2019–2021
Eesti Arst: 101 (Lisa 5), 47, 2022
11Keernik M., Tammur P., Šamarina U., Kaare A., Palk K., Ilisson P., Tooming M.
Landscape of genetic alterations of Estonian patients with MDS and AML diagnosis
Eesti Arst: 101 (Supplement 4), 30, 2022
12Kurg K., Planken A., Kurg R.
Melanoomipatsientide vereseerumist puhastatud ekstratsellulaarsete vesiikulite proteoomiline ja biokeemiline analüüs
Eesti Arst: 101 (Lisa 5), 19, 2022
13Kurg K., Planken A., Kurg R.
Proteomic and biochemical analysis of extracellular vesicles isolated from the blood serum of patients with melanoma
Eesti Arst: 101 (Supplement 4), 40, 2022
14Kõljalg S., Vaikjärv R., Smidt I., Rööp T., Chakrabarti A., Kasenõmm P., Mändar R.
Erütritooli ja ksülitooli efekt peritonsillaarset abstsessi põhjustanud Streptococcus pyogenes’e tüvedele
Eesti Arst: 101 (Lisa 5), 31, 2022
15Kõre AC., Serg M., Voitk J., Roose I., Eha J., Pauklin P., Kampus P.
Resünkroniseeriva ja kardioverter-defibrillaatorravi kandidaatide tsentraalne hemodünaamiline profii
Eesti Arst: 101 (Lisa 5), 11, 2022
16Kütt M.
Harmonisation in satellite labs
Eesti Arst: 101 (Supplement 4), 30, 2022
17Kütt M.
What do people ask from laboratory doctors?
Eesti Arst: 101 (Supplement 4), 25, 2022
18Laisaar T., Vanakesa T., Sarana B., Almre I., Saar A.
Nationwide Activity of Lung Cancer Surgery Before and During the COVID-19 Pandemic
Journal of Thoracic Oncology: 17 (9 Suppl), S309-S310, 2022
19Luksta M., Ümarik T., Bausys A., Reinsoo A., Rackauskas R., Anglickiene G., Kryzauskas M., Tõnismäe K., Senina V., Seinin D., Bausys R., Strupas K.
The optimal timing for gastrectomy after neoadjuvant chemotherapy
European Journal of Surgical Oncology: 48 (2), e178, 2022
20Mihnovitš V., Põld K., Paasma R.
Cortinarius rubellus poisoning in Estonia: a case series
Clinical Toxicology: 60 (Suppl 1), 32, 2022
21O'Brien MER., Paz-Ares L., Jha N., Dafni U., Oselin K., Havel L., Esteban E., Isla D., Martinez-Marti A., Faehling M., ...
EORTC-1416-LCG/ETOP 8-15 - PEARLS/KEYNOTE-091 study of pembrolizumab versus placebo for completely resected early-stage non-small cell lung cancer (NSCLC): Outcomes in subgroups related to surgery, disease burden, and adjuvant chemotherapy use
Journal of Clinical Oncology: 40 (16 Suppl), Tees nr 8512, 2022
22Paats J., Adoberg A., Arund J., Fridolin I., Holmar J., Leis L., Pilt K., Tanner R., Uhlin F., Luman M.
Medicines intake influences accuracy of the uremic retention molecules' optical monitoring in spent dialysate: the case of uremic toxin uric acid and paracetamol
Kidney International Reports: 7 (2 Suppl), S277-S278, 2022
23Peebo K., Saluveer E., Küünarpuu H., Orgse T., Harro J.
First-Episode Psychosis Integrative Treatment: Estonian Experience
Eesti Arst: 101 (Lisa 2), 54, 2022
24Peters S., Besse B., Marreaud S., Dafni U., Oselin K., Havel L., Esteban Gonzalez E., Isla D., Martinez-Marti A., Faehling M., Tsuboi M., Lee JS., Nakagawa K., Yang J., Keller SM., Mauer ME., Jha N., Stahel RA., Paz-Ares L., O’Brien MER.
PD-L1 expression and outcomes of pembrolizumab and placebo in completely resected stage IB-IIIA NSCLC: Subgroup analysis of PEARLS/KEYNOTE-091
Annals of Oncology: 33 (Suppl 7), Tees nr 930MO, 2022
25Pikta M., Saks K., Ross M., Banys V.
Testing strategy for laboratory monitoring of Hemophilia A patients treated with Emicizumab
Clinica Chimica Acta: 530 (Suppl 1), S186, 2022
26Pikta M., Szanto T., Banys V.
Evaluation of within-subject variation of VWF multimers assay
Research and Practice in Thrombosis and Haemostasis: 6 (Suppl 1), 616, 2022
27Põder H., Kaasik B., Sokk-Kaha A.
Clinical case of infantile hemangioma – is it as easy to treat as to diagnose?
5th Baltic Paediatric Congress & 23rd Estonian Paediatric Association Congress. Programme and abstract book: 103, 2022
28Roht L., Hyldebrandt HK., Stormorken AT., Nordgarden H., Sijmons RH., Bos DK., Riegert-Johnson D., Mantia-Macklin S., Muru K., Kahre T., Õunap K.
Phenotype of six families with AXIN2-oligodontia-colorectal cancer syndrome. Cleft palate as a new feature of this syndrome?
European Journal of Human Genetics: 30 (Suppl 1), 372, 2022
29Roht L., Põder H., Paluste M., Veri K.
Myotonic dystrophy type 1 - different clinical manifestations in one family
16th BCNA Conference: 53, 2022
30Saar M., Vaikjärv R., Parm Ü., Jaagura M., Kasenõmm P., Štšepetova J., Mändar R.
Tonsillide ja abstsessi mäda mikrobioomi molekulaarne analüüs peritonsillaarse abstsessi korral
Eesti Arst: 101 (Lisa 5), 13, 2022
31Schwarz G., Bonato S., Lanfranconi S., Matusevicius M., Ghione I., Valcamonica G., Tsivgoulis G., Paiva Nunes A., Mancuso M., Zini A., Candelaresi P., Rand VM., Comi GP., Mazya MV., Ahmed N.
Safety and efficacy of endovascular thrombectomy plus intravenous thrombolysis vs. intravenous thrombolysis alone in mild symptoms strokes with large vessel occlusion: propensity score matched analysis
European Stroke Journal: 7 (1 Suppl), 114, 2022
32Sepp T., Kukk L., Korotõtš D.
Radiation-induced rectourethral fistulas, single centre experience in management
European Urology Open Science: 40 (Suppl 1), S46, 2022
33Serban M., Gallois M., Urtubey T., Nout R., de Leeuw A., Fokdal L., Assenholt M., Spampinato S., Bruheim K., Segedin B., ..., Valgma M.
Effect of dose and fractionation de-escalation in low-risk cervix cancer treated with EBRT and BT
Radiotherapy and Oncology: 170 (Suppl 1), S451-S453, 2022
34Serg M.
New drugs for treating dyslipidemia
Eesti Arst: 101 (Lisa 2), 37, 2022
35Säflund M., Matusevicius M., Egido JA., Ferro JM., Kõrv J., Melis M., Peeters A., Petruzzellis M., Rand VM., Vilionskis A., Mazya MV., Moreira T., Ahmed N.
Initiation of direct oral anticoagulation after reperfusion therapy in ischemic stroke in clinical practice: results from SITS-International Stroke Registry
European Stroke Journal: 7 (1 Suppl), 201, 2022
36Zordania R., Kuuse K., Murumets Ü., Tarelkin E., Roht L.
Genetic counselling of patients with mental retardation/disability and autism spectrum disorders
5th Baltic Paediatric Congress & 23rd Estonian Paediatric Association Congress. Programme and abstract book: 73-74, 2022
37Tamm M., Annilo T., Oselin K., Kals M., Keerma K., Kivistik PA., Nurm M., Saare M., Jaal J., Tõnisson N.
Liquid biopsy in lung cancer patients shows advantages compared to FFPE tissue mutational analysis
European Journal of Human Genetics: 30 (Suppl 1), 405-406, 2022
38Tomberg K., Pikta M.
Hemogram reference values in Estonia
Eesti Arst: 101 (Supplement 4), 13, 2022
39Vaagen K., Zemtsovskaja G.
Harmonization of electrophoretic investigations in the evaluation of monoclonal gammopathies in Estonia
Eesti Arst: 101 (Supplement 4), 29, 2022
40Valter A.
Current state of art - cancer immunotherapy in clinical practice
Eesti Arst: 101 (Lisa 2), 26, 2022
41Valter A., Luhari L., Pisarev H., Truumees B., Planken A., Smolander OP., Oselin K.
Genetic alterations as independent prognostic factors to predict the type of recurrence of lung cancer
Annals of Oncology: 33 (Suppl 7), Tees nr 1684P, 2022
42Viigimaa M.
Erectile dysfunction in cardiovascular disorders
Journal of Rehabilitation Medicine: 54 (Suppl), 9, 2022
43Villarrubia J., Munoz G., Ciubotariu C., Dominguez-Ruiz M., Piris-Villaespesa M., Unceta M., Ceberio L., Church H., Norouzi M., Ross M., Perez-de Pedro I., Stepien KM., del Castillo FJ.
Adult acid sphingomyelinase deficiency (Niemann-Pick disease type B): A difficult pathway to a diagnosis in 4 novel cases
Molecular Genetics and Metabolism: 135 (2), S125, 2022
Muud publikatsioonid
1Adoberg A.
Kui neerud on natuke laisad ehk kuidas seletada patsiendile neeruanalüüside tulemusi
Perearst: 9 (183), 49-51, 2022
2Ambos A.
Ameerika Diabeedi Assotsiatsiooni 2022. aasta diabeedi käsitluse standardid
Lege Artis: 1 (6), 53-57, 2022
3Anton L.
Pulmonaalhüpertensiooni käsitlus 2022. aasta Euroopa Kardioloogide Seltsi ravijuhendis
Lege Artis: 7 ( 6), 12-15, 2022
4Eisen M.
Raske atoopilise dermatiidi ravivõimalused EuroGuiDermi juhendi põhjal kohandatuna Eesti oludele
Lege Artis: 8 (6), 27-28, 2022
5Elme A.
Erakorraliste onkoloogiliste olukordade äratundmine esmatasandil
Perearst: 8 (182), 26-29, 2022
6Helmdorf M.
Statiinravi alustamine eakatel
Perearst: 7 (181), 22-24, 2022
7Kaarde P.
Hormoonasendusravi võimalikud kasud ja riskid
Lege Artis: 2 (6), 16-18, 2022
8Kaha T.
Patoloogiliste armide korral võib leida abi konservatiivsest ravi
Perearst: 2 (176), 45-48, 2022
9Kaha T.
Põletuste ravist pereõdedele
Pereõde: 3 (39), 41-42, 2022
10Kala K.
Kuiva silma sündroom
Perearst: 10 (184), 45-47, 2022
11Kaur I.
Kaalukirurgia ja metaboolne kirurgia
Lege Artis: 4 (6), 12-16, 2022
12Kippasto N.
Kasvaja metastaasid
Perearst: 10 (184), 16-18, 2022
13Kõdar H., Palk K., Ross M.
Ägedad leukeemiad ja nende eduka ravi kaugmõjud
Perearst: 2 (176), 15-18, 2022
14Kütner R.
Rinnatervis on oluline kogu perele
Lege Artis: 5 (6), 3, 2022
15Kütner R., Roht L.
Geneetiliste faktorite roll rinnavähi tekkes
Perearst: 1 (175), 42-44, 2022
16Kütt M.
Tsirkuleerivad ja koelised kasvajamarkerid ning nende kasutamine kliinilises praktikas
Lege Artis: 1 (6), 20-25, 2022
17Lauri V.
Autismispektri häire – mida see endast kujutab, kuidas üles leida eripära ja kuidas sekkuda?
Perearst: 3 (177), 13-16, 2022
18Lotman EM.
Cor pulmonale
Perearst: 4 (178), 56-59, 2022
19Lotman EM.
Haigusjuht: tahhükardia-bradükardia sündroom
Lege Artis: 1 (6), 81-83, 2022
20Lotman EM.
Suukaudsete antitrombootiliste ravimite kasutamine kodade virvendusarütmia ja aterosklerootilise kardiovaskulaarhaiguse ravis
Perearst: 6 (180), 55-58, 2022
21Luman M.
Neerukahjustusega diabeetiku ravivõimalused ja -eelistused
Perearst: 3 (177), 47-53, 2022
22Lõokene M.
Depressioon meestel – mida märgata ja kuidas aidata?
Perearst: 4 (178), 63-66, 2022
23Lõokene M.
Ülevaade transkraniaalsest alalisvoolustimulatsioonist
Perearst: 7 (181), 57-60, 2022
24Mukk P.
GOLD 2022 uuendused pööravad tähelepanu ka COVID-19 pandeemiale
Perearst: 5 (179), 59-64, 2022
25Niine-Roolaht EM.
Euroopa endomeetriumivähi ravijuhendi lühitutvustus
Teataja / Eesti Naistearstide Selts: 69, 26-28, 2022
26Putnik K.
Melanoomi esinemissagedus kasvab kogu maailmas
Lege Artis: 4 (6), 43-47, 2022
27Rahu M.
Viskosuplementatsioon osteoartriidi korral
Lege Artis: 6 (6), 14-17, 2022
28Roht L.
Rinnavähist geneetiku vaatevinklist
Lege Artis: 5 (6), 8-11, 2022
29Rugo M.
Sagedasemad vulvovaginiidid
Perearst: 8 (182), 59-60, 2022
30Rugo M.
Viljatuse põhjuste kirurgilised ravivõimalused naistel
Lege Artis: 2 (6), 10-12, 2022
31Salus M.
Polüneuropaatia – diagnoosimise põhitõed ja esmane käsitlus
Perearst: 11 (185), 74-77, 2022
32Salus M.
Vitamiin B12 inimese närvisüsteemis
Lege Artis: 4 (6), 68-70, 2022
33Serg M., Tsvetkov E., Sepp A., Viigimaa M.
Düslipideemia müokardi­infarktiga patsientidel – multidistsiplinaarne analüüs
Lege Artis: 5 (6), 45-47, 2022
34Sergejeva S.
Kroonilised obstruktiivsed kopsuhaigused: kokkuvõte hiljutisest kopsuarstide seminarist
Perearst: 8 (182), 31-33, 2022
35Sergejeva S., Melnikova R., Sadam T.
Täiskasvanuea allergilisest astmast perearstile
Perearst: 5 (179), 51-56, 2022
36Suuroja T.
Igal aastal avastatakse Eestis umbes 100 uut neuroendokriinkasvaja juhtu
Perearst: 10 (184), 67-68, 2022
37Varik M., Kõdar H
Tsütopeeniad ja nende käsitlus
Perearst: 9 (183), 55-60, 2022
38Varik M., Kõdar H.
Tsütopeeniad ja nende käsitlus
Perearst: 10 (184), 19-23, 2022
39Viigimaa I.
Kroonilise lümfotsüütleukeemia ravi – saabunud on uus ajastu
Lege Artis: 7 ( 6), 47-48, 2022
40Viigimaa M.
Oleme unustanud, et rohkem kui pool südame-veresoonkonnahaigustest on ennetatavad
Perearst: 4 (178), 31, 2022
41Viigimaa M.
Oleme unustanud, et rohkem kui pool südame-veresoonkonnahaigustest on ennetatavad
Pereõde: 2 (38), 33, 2022
42Viigimaa M., Tänavsuu T.
Terve südame raamat
Terve südame raamat: 108, 2022
43Viks L.
GOLD-i 2022. aasta ravijuhend: kroonilise obstruktiivse kopsuhaiguse ravisoovitused
Perearst: 1 (175), 59-65, 2022
44Viks L.
Kroonilise obstruktiivse kopsuhaiguse olemusest ja hapnikravist
Lege Artis: 2 (6), 41-46, 2022
45Viks L.
Kroonilise obstruktiivse kopsuhaiguse olemusest ja hapnikravist
Perearst: 6 (180), 37-41, 2022